{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:22:16Z","timestamp":1792059736506,"version":"4.4.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    This article proposes that ibogaine\u2019s induction of GDNF, modulation of glutamate and dopamine signaling, and reopening of plasticity represent a unified mechanism capable of restoring reward system fidelity across disorders. This includes addiction, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and eating disorders, amongst others. These conditions are labelled as distinct and separate yet share disrupted dopaminergic and glutamatergic signaling within the mesocorticolimbic circuitry as a common underlying dysfunction, resulting in maladaptive reinforcement and motivational dysregulation. Ibogaine, a little-known indole alkaloid derived from\n                    <jats:italic>Tabernanthe iboga<\/jats:italic>\n                    , has shown distinct neurobiological effects that seem to restore normal reward processing through glial cell line-derived neurotrophic factor (GDNF) upregulation, receptor modulation, and enhanced neuroplasticity. Historical, preclinical, and observational evidence suggests that ibogaine\u2019s mechanism of action is consistent with an action on underlying reward system dysfunction rather than only on surface symptoms. However, there are some safety concerns. Ibogaine causes hERG channel inhibition, so the therapy requires adherence to strict medical protocols. This review hypothesizes that ibogaine\u2019s neurotrophic and receptor-modulating properties act as a unifying mechanism for restoring reward-system function across diagnostic boundaries. Unlike prior ibogaine reviews that focus on addiction, this paper integrates findings across trauma, compulsive behavior, and affective disorders through the common lens of reward-circuit dysfunction. The mechanisms described here support a theoretical framework that requires empirical validation, and the predictions derived from this model are outlined within the paper.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2025.1744383","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:32:44Z","timestamp":1764837164000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Ibogaine\u2019s potential role in supporting reward system recovery across diagnostic boundaries"],"prefix":"10.3389","volume":"16","author":[{"given":"Mark","family":"Nicolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Ibogaine: a review","volume":"56","author":"Alper","year":"2001","journal-title":"Chem. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/105504999305848","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"Am. J. Addict."},{"key":"B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.nut.2011.11.002","article-title":"Further developments in the neurobiology of food and addiction: update on the state of the science","volume":"28","author":"Avena","year":"2012","journal-title":"Nutrition"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1016\/j.prenap.2023.100006","article-title":"Ibogaine pharmacogenetics and safety considerations","author":"Boukandou","year":"2023","journal-title":"Prev. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes","volume":"44","author":"Brown","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1369-1600.2010.00251.x","article-title":"Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and alcohol consumption","volume":"15","author":"Carnicella","year":"2010","journal-title":"Addict. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41591-023-02705-w","article-title":"Magnesium\u2013ibogaine therapy in veterans with traumatic brain injuries: the stanford traumatic injury to the CNS protocol (MISTIC)","volume":"30","author":"Cherian","year":"2024","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive\u2013compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"608520","DOI":"10.3389\/fnins.2020.608520","article-title":"Dopaminergic system alteration in anxiety and compulsive disorders: a systematic review of neuroimaging studies","volume":"14","author":"Dong","year":"2020","journal-title":"Front. Neurosci."},{"key":"B9","volume-title":"Bwiti: an ethnography of the religious imagination in Africa","author":"Fernandez","year":"1982"},{"key":"B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s11920-013-0396-x","article-title":"Altered brain reward circuits in eating disorders: chicken or egg","volume":"15","author":"Frank","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jamapsychiatry.2018.2151","article-title":"Association of brain reward learning response with harm avoidance, weight gain, and hypothalamic effective connectivity in adolescent anorexia nervosa","volume":"75","author":"Frank","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e11305","DOI":"10.7554\/eLife.11305","article-title":"Characterizing a psychiatric symptom dimension related to deficits in goal directed control","volume":"5","author":"Gillan","year":"2016","journal-title":"eLife"},{"key":"B13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.1998.tb08237.x","article-title":"Mechanisms of antiaddictive actions of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener","volume":"844","author":"Glick","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B14","first-page":"71","article-title":"Pharmacodynamics and therapeutic applications of iboga and ibogaine","volume":"6","author":"Goutarel","year":"1993","journal-title":"Psychedelic Monogr. Essays"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1096\/fj.06-6394fje","article-title":"Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug ibogaine","volume":"20","author":"He","year":"2006","journal-title":"FASEB J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nn.4238","article-title":"Computational psychiatry as a bridge from neuroscience to clinical applications","volume":"19","author":"Huys","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1039\/D0NP00033G","article-title":"The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs","volume":"38","author":"Iyer","year":"2021","journal-title":"Nat. Product. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrn2682","article-title":"New insights into symptoms and neurocircuit function of anorexia nervosa","volume":"10","author":"Kaye","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1369-1600.2012.00447.x","article-title":"Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk","volume":"19","author":"Koenig","year":"2012","journal-title":"Addict. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1037\/abn0000258","article-title":"The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies","volume":"126","author":"Kotov","year":"2017","journal-title":"J. Abnorm. Psychol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"559401","DOI":"10.3389\/fpsyt.2021.559401","article-title":"Reward processing and circuit dysregulation in posttraumatic stress disorder","volume":"12","author":"Lokshina","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","article-title":"Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling","volume":"69","author":"L\u00fcscher","year":"2011","journal-title":"Neuron"},{"key":"B24","doi-asserted-by":"publisher","first-page":"855000","DOI":"10.3389\/fphar.2022.855000","article-title":"Drug transporters ABCB1 (P-gp) and OATP, but not drug-metabolizing enzyme CYP3A4, affect the pharmacokinetics of the psychoactive alkaloid ibogaine and its metabolites","volume":"13","author":"Martins","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2019.00193","article-title":"Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits","volume":"10","author":"Marton","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/2045125315626073","article-title":"Ibogaine-associated cardiac arrest and death: case report and review of the literature","volume":"6","author":"Meisner","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neubiorev.2015.01.019","article-title":"Reward functioning in PTSD: a systematic review exploring the mechanisms underlying anhedonia","volume":"51","author":"Nawijn","year":"2015","journal-title":"Neurosci. & Biobehav. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","article-title":"Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study","volume":"44","author":"Noller","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbi.2010.10.003","article-title":"A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities","volume":"25","author":"Pace","year":"2011","journal-title":"Brain, Behav. Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00429-010-0258-9","article-title":"Interoception in anxiety and depression","volume":"214","author":"Paulus","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"B31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0031-6997(25)06842-5","article-title":"100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug","volume":"47","author":"Popik","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1037\/a0013600","article-title":"Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study","volume":"117","author":"Stice","year":"2008","journal-title":"J. Abnorm. Psychol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fphar.2019.00404","article-title":"Therapeutic challenges of post-traumatic stress disorder: focus on the dopaminergic system","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0361-9230(99)00053-2","article-title":"The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes","volume":"48","author":"Wells","year":"1999","journal-title":"Brain Res. Bull."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:32:45Z","timestamp":1764837165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1744383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":37,"alternative-id":["10.3389\/fphar.2025.1744383"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1744383","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"article-number":"1744383"}}